2021 Coagulation Factor Assay Testing Market: US, Europe, Japan--Competitive Landscape, Country Forecasts, Innovative Technologies and Instrumentation
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more standardized, offering opportunities for quality control products and services.
The report is available by section, and can be customized to specific information needs and budget.
Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Factor Assays testing closer to the patient, creating additional opportunities and challenges for suppliers.
This report presents a detailed analysis of the Factor Assays testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 295 pages and 85 tables
II. Worldwide Market and Technology Overview
A. Introduction
B. Factor Assays: Clinical Significance
and Current Laboratory Procedures
1. Introduction
2. Factor II
3. Factor V/Factor V Leiden
4. Factor VII
5. Factor VIII
6. Factor IX
7. Factor IXa
8. Factor X (Stuart Factor)
9. Factor Xa
10. Factor XI
11. Factor XII
12. Factor XIII
C. Instrumentation: Review of latest analyzers from Bio/Data, Cardiovascular
Diagnostics, Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory,
NexusDx, Roche Diagnostics, Siemens Healthineers, Sysmex, Teco Diagnostics.
D. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
III. France: Test Volume Forecasts by Market Segment
IV. Germany: Test Volume Forecasts by Market Segment
V. Italy: Test Volume Forecasts by Market Segment
VI. Japan: Test Volume Forecasts by Market Segment
VII. Spain: Test Volume Forecasts by Market Segment
VIII. UK: Test Volume Forecasts by Market Segment
IX. USA: Test Volume Forecasts by Market Segment
X. Design Criteria For Decentralized Testing Products
XI. Alternative Market Penetration
Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product
Complexity
3. Customer
Preference
4. Established
Suppliers
5. Emerging
Suppliers
6. Major Types Of Distributors
7. Market
Segmentation
XII. Potential Market Entry Barriers and
Risks
A. Market
Maturity B. Cost
Containment C.
Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
CompetitiveAssessments
Abbott
Accriva
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher
List Of Tables
Major Companies Developing or Marketing Factor Assay TestsFrance
Factor II Test Volume Forecasts by Market Segment
France
Factor V Test Volume Forecasts by Market Segment
France
Factor V Leiden Test Volume Forecasts by Market Segment
France
Factor VII Test Volume Forecasts by Market Segment
France
Factor VIII Test Volume Forecasts by Market Segment
France
Factor IX Test Volume Forecasts by Market Segment
France
Factor IXa Test Volume Forecasts by Market Segment
France
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
France
Factor Xa Test Volume Forecasts by Market Segment
France
Factor XI Test Volume Forecasts by Market Segment
France
List of Tables (continued)
Factor XII Test Volume Forecasts by Market Segment
France
Factor XIII Test Volume Forecasts by Market Segment
Germany
Factor II Test Volume Forecasts by Market Segment
Germany
Factor V Test Volume Forecasts by Market Segment
Germany
Factor V Leiden Test Volume Forecasts by Market Segment
Germany
Factor VII Test Volume Forecasts by Market Segment
Germany
Factor VIII Test Volume Forecasts by Market Segment
Germany
Factor IX Test Volume Forecasts by Market Segment
Germany
Factor IXa Test Volume Forecasts by Market Segment
Germany
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Germany
Factor Xa Test Volume Forecasts by Market Segment
Germany
Factor XI Test Volume Forecasts by Market Segment
Germany
Factor XII Test Volume Forecasts by Market Segment
List of Tables (continued)
Germany
Factor XIII Test Volume Forecasts by Market Segment
Italy
Factor II Test Volume Forecasts by Market Segment
Italy
Factor V Test Volume Forecasts by Market Segment
Italy
Factor V Leiden Test Volume Forecasts by Market Segment
Italy
Factor VII Test Volume Forecasts by Market Segment
Italy
Factor VIII Test Volume Forecasts by Market Segment
Italy
Factor IX Test Volume Forecasts by Market Segment
Italy
Factor IXa Test Volume Forecasts by Market Segment
Italy
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Italy
Factor Xa Test Volume Forecasts by Market Segment
Italy
Factor XI Test Volume Forecasts by Market Segment
Italy
Factor XII Test Volume Forecasts by Market Segment
Italy
Factor XIII Test Volume Forecasts by Market Segment
List of Tables (continued)
Japan
Factor II Test Volume Forecasts by Market Segment
Japan
Factor V Test Volume Forecasts by Market Segment
Japan
Factor V Leiden Test Volume Forecasts by Market Segment
Japan
Factor VII Test Volume Forecasts by Market Segment
Japan
Factor VIII Test Volume Forecasts by Market Segment
Japan
Factor IX Test Volume Forecasts by Market Segment
Japan
Factor IXa Test Volume Forecasts by Market Segment
Japan
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Japan
Factor Xa Test Volume Forecasts by Market Segment
Japan
Factor XI Test Volume Forecasts by Market Segment
Japan
Factor XII Test Volume Forecasts by Market Segment
Japan
Factor XIII Test Volume Forecasts by Market Segment
Spain
Factor II Test Volume Forecasts by Market Segment
List of Tables (continued)
Spain
Factor V Test Volume Forecasts by Market Segment
Spain
Factor V Leiden Test Volume Forecasts by Market Segment
Spain
Factor VII Test Volume Forecasts by Market Segment
Spain
Factor VIII Test Volume Forecasts by Market Segment
Spain
Factor IX Test Volume Forecasts by Market Segment
Spain
Factor IXa Test Volume Forecasts by Market Segment
Spain
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
Spain
Factor Xa Test Volume Forecasts by Market Segment
Spain
Factor XI Test Volume Forecasts by Market Segment
Spain
Factor XII Test Volume Forecasts by Market Segment
Spain
Factor XIII Test Volume Forecasts by Market Segment
U.K.
Factor II Test Volume Forecasts by Market Segment
U.K.
Factor V Test Volume Forecasts by Market Segment
List of Tables (continued)
U.K.
Factor V Leiden Test Volume Forecasts by Market Segment
U.K.
Factor VII Test Volume Forecasts by Market Segment
U.K.
Factor VIII Test Volume Forecasts by Market Segment
U.K.
Factor IX Test Volume Forecasts by Market Segment
U.K.
Factor IXa Test Volume Forecasts by Market Segment
U.K.
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
U.K.
Factor Xa Test Volume Forecasts by Market Segment
U.K.
Factor XI Test Volume Forecasts by Market Segment
U.K.
Factor XII Test Volume Forecasts by Market Segment
U.K.
Factor XIII Test Volume Forecasts by Market Segment
U.S.A.
Factor II Test Volume Forecasts by Market Segment
U.S.A.
Factor V Test Volume Forecasts by Market Segment
U.S.A.
Factor V Leiden Test Volume Forecasts by Market Segment
List of Tables (continued)
U.S.A.
Factor VII Test Volume Forecasts by Market Segment
U.S.A.
Factor VIII Test Volume Forecasts by Market Segment
U.S.A.
Factor IX Test Volume Forecasts by Market Segment
U.S.A.
Factor IXa Test Volume Forecasts by Market Segment
U.S.A.
Factor X (Stuart Factor) Test Volume Forecasts by Market
Segment
U.S.A.
Factor Xa Test Volume Forecasts by Market Segment
U.S.A.
Factor XI Test Volume Forecasts by Market Segment
U.S.A.
Factor XII Test Volume Forecasts by Market Segment
U.S.A.
Factor XIII Test Volume Forecasts by Market Segment
Global Neuromodulation Devices Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2030
The neuromodulation devices market is anticipated to grow at a CAGR of 6.5% over the forecast period of 20202028. According to a study published by Insure Insights on the neuromodulation
USD 3950 View ReportGlobal Neuromarketing Solutions Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030
The Global Neuromarketing Solutions market is anticipated to rise at a value CAGR of 9.65% over 20202028. According to a study published by Insure Insights on the Global Neuromarketing Solutions
USD 3950 View ReportGlobal Coagulation Factor IX Market Research Report 2021-2025
Coagulation factor IX is a man-made protein similar to a natural protein in the body that helps the blood to clot. In the context of China-US trade war and COVID-19
USD 3200 View ReportCOVID-19 Outbreak-Global Human Coagulation Factor Viii Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
The Human Coagulation Factor Viii market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.Under COVID-19 outbreak
USD 3660 View ReportFill The Form For Sample Request